Rocket Doctor AI

Rocket Doctor AI FCF per Share

Delisted

The Free Cash Flow per Share of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is -0.10 CAD. In the previous year, Free Cash Flow per Share was -0.05 CAD — a change of 97.71% (lower).

FCF per Share

-0.10CAD

YoY

97.71%

Last updated:

Free Cash Flow per Share of Rocket Doctor AI is 2024 -0.10 CAD. Free Cash Flow per Share of Rocket Doctor AI was 2023 -0.05 CAD. It decreases by 97.71% lower compared to the previous year.

The Rocket Doctor AI FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
-0.00 CAD
Jan 1, 2018
-0.00 CAD
Jan 1, 2019
-0.01 CAD
Jan 1, 2020
-0.30 CAD
Jan 1, 2021
-0.97 CAD
Jan 1, 2022
-0.22 CAD
Jan 1, 2023
-0.05 CAD
Jan 1, 2024
-0.10 CAD
The Rocket Doctor AI FCF per Share history
YEARFCF per ShareYoY
-0.10CAD+97.71%
-0.05CAD-76.59%
-0.22CAD-77.29%
-0.97CAD+218.90%
-0.30CAD+3,847.82%
-0.01CAD+374.58%
-0.00CAD+36.99%
-0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rocket Doctor AI stock

Free Cash Flow per Share of Rocket Doctor AI is -0.10 CAD in 2024.

Free Cash Flow per Share of Rocket Doctor AI changed from -0.05 CAD to -0.10 CAD, representing a 97.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI